NFAT5 regulates the canonical Wnt pathway and is required for cardiomyogenic differentiation

Biochemical and Biophysical Research Communications

Volumn 426, Issue 3, 2012, Pages 317-323

  Adachi, Atsuo ^a   Takahashi, Tomosaburo ^a   Ogata, Takehiro ^a   Imoto Tsubakimoto, Hiroko ^a   Nakanishi, Naohiko ^a   Ueyama, Tomomi ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Canonical Wnt signaling; Cardiomyogenesis; Mesodermal induction; NFAT5; P19CL6 cells

Indexed keywords

DICKKOPF 1 PROTEIN; DIMETHYL SULFOXIDE; MESSENGER RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT5; UNCLASSIFIED DRUG; WNT3 PROTEIN; WNT3A PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEART MUSCLE CELL; MESODERM; MUSCLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION INITIATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; EMBRYONIC STEM CELLS; HEART; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MYOCYTES, CARDIAC; ORGANOGENESIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; PROTEOLYSIS; TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84866945787     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.069     Document Type: Article

References (31)

1. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev. Biol. 2003, 258:1-19.
2. Evans S.M., Yelon D., Conlon F.L., Kirby M.L. Myocardial lineage development. Circ. Res. 2010, 107:1428-1444.
3. Ho S.N. The role of NFAT5/TonEBP in establishing an optimal intracellular environment. Arch. Biochem. Biophys. 2003, 413:151-157.
4. Halterman J.A., Kwon H.M., Wamhoff B.R. Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am. J. Physiol. Cell. Physiol. 2012, 302:C1-C8.
5. Maouyo D., Kim J.Y., Lee S.D., Wu Y., Woo S.K., Kwon H.M. Mouse TonEBP-NFAT5: expression in early development and alternative splicing. Am. J. Physiol. Renal. Physiol. 2002, 282:F802-F809.
6. Lopez-Rodriguez C., Antos C.L., Shelton J.M., Richardson J.A., Lin F., Novobrantseva T.I., Bronson R.T., Igarashi P., Rao A., Olson E.N. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc. Natl. Acad. Sci. U S A 2004, 101:2392-2397.
7. Go W.Y., Liu X., Roti M.A., Liu F., Ho S.N. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl. Acad. Sci. U S A 2004, 101:10673-10678.
8. Mak M.C., Lam K.M., Chan P.K., Lau Y.B., Tang W.H., Yeung P.K., Ko B.C., Chung S.M., Chung S.K. Embryonic lethality in mice lacking the nuclear factor of activated T cells 5 protein due to impaired cardiac development and function. PLoS One 2011, 6:e19186.
9. Habara-Ohkubo A. Differentiation of beating cardiac muscle cells from a derivative of P19 embryonal carcinoma cells. Cell Struct. Funct. 1996, 21:101-110.
10. Ueyama T., Kasahara H., Ishiwata T., Nie Q., Izumo S. Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis. Mol. Cell Biol. 2003, 23:9222-9232.
11. Marikawa Y., Tamashiro D.A., Fujita T.C., Alarcon V.B. Aggregated P19 mouse embryonal carcinoma cells as a simple in vitro model to study the molecular regulations of mesoderm formation and axial elongation morphogenesis. Genesis 2009, 47:93-106.
12. Ko B.C., Turck C.W., Lee K.W., Yang Y., Chung S.S. Purification, identification, and characterization of an osmotic response element binding protein. Biochem. Biophys. Res. Commun. 2000, 270:52-61.
13. Kitamura R., Takahashi T., Nakajima N., Isodono K., Asada S., Ueno H., Ueyama T., Yoshikawa T., Matsubara H., Oh H. Stage-specific role of endogenous Smad2 activation in cardiomyogenesis of embryonic stem cells. Circ. Res. 2007, 101:78-87.
14. Gessert S., Kuhl M. The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ. Res. 2010, 107:186-199.
15. Harwood A.J. Regulation of GSK-3: a cellular multiprocessor. Cell 2001, 105:821-824.
16. Sato N., Meijer L., Skaltsounis L., Greengard P., Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004, 10:55-63.
17. Foley A.C., Gupta R.W., Guzzo R.M., Korol O., Mercola M. Embryonic heart induction. Ann. N. Y. Acad. Sci. 2006, 1080:85-96.
18. Yamaguchi T.P., Takada S., Yoshikawa Y., Wu N., McMahon A.P. T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification. Genes. Dev. 1999, 13:3185-3190.
19. Arnold S.J., Stappert J., Bauer A., Kispert A., Herrmann B.G., Kemler R. Brachyury is a target gene of the Wnt/β -catenin signaling pathway. Mech. Dev. 2000, 91:249-258.
20. Galceran J., Hsu S.C., Grosschedl R. Rescue of a Wnt mutation by an activated form of LEF-1: regulation of maintenance but not initiation of Brachyury expression. Proc. Natl. Acad. Sci. U S A 2001, 98:8668-8673.
21. Bondue A., Blanpain C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ. Res. 2010, 107:1414-1427.
22. Stadtmueller B.M., Hill C.P. Proteasome activators. Mol. Cell. 2011, 41:8-19.
23. Liu P., Wakamiya M., Shea M.J., Albrecht U., Behringer R.R., Bradley A. Requirement for Wnt3 in vertebrate axis formation. Nat. Genet. 1999, 22:361-365.
24. Yoshikawa Y., Fujimori T., McMahon A.P., Takada S. Evidence that absence of Wnt-3a signaling promotes neuralization instead of paraxial mesoderm development in the mouse. Dev. Biol. 1997, 183:234-242.
25. Morkel M., Huelsken J., Wakamiya M., Ding J., van de Wetering M., Clevers H., Taketo M.M., Behringer R.R., Shen M.M., Birchmeier W. Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 2003, 130:6283-6294.
26. Tran T.H., Wang X., Browne C., Zhang Y., Schinke M., Izumo S., Burcin M. Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem cells 2009, 27:1869-1878.
27. Piccolo S., Agius E., Leyns L., Bhattacharyya S., Grunz H., Bouwmeester T., De Robertis E.M. The head inducer cerberus is a multifunctional antagonist of nodal BMP and Wnt signals. Nature 1999, 397:707-710.
28. Reid C.D., Zhang Y., Sheets M.D., Kessler D.S. Transcriptional integration of Wnt and nodal pathways in establishment of the spemann organizer. Dev. Biol. 2012.
29. Nakamura T., Sano M., Songyang Z., Schneider M.D. A Wnt- and β-catenin-dependent pathway for mammalian cardiac myogenesis. Proc. Natl. Acad. Sci. U S A 2003, 100:5834-5839.
30. Dunwoodie S.L. Combinatorial signaling in the heart orchestrates cardiac induction, lineage specification and chamber formation. Semin. Cell. Dev. Biol. 2007, 18:54-66.
31. Ito T., Fujio Y., Takahashi K., Azuma J. Degradation of NFAT5, a transcriptional regulator of osmotic stress-related genes, is a critical event for doxorubicin-induced cytotoxicity in cardiac myocytes. J. Biol. Chem. 2007, 282:1152-1160.